ET
ADMA icon

Entropy Technologies’s ADMA Biologics ADMA Stock Holding History

Entropy Technologies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
+22,602
New +$206K 0.01% 896
2026
Q1 		– Sell
-12,144
Closed -$222K – 860
2025
Q4 		$222K Buy
+12,144
New +$205K 0.01% 782
2025
Q2 		– Sell
-17,021
Closed -$338K – 758
2025
Q1 		$338K Buy
+17,021
New +$294K 0.03% 513
2024
Q4 		– Sell
-37,850
Closed -$757K – 700
2024
Q3 		$757K Buy
+37,850
New +$589K 0.08% 332

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Entropy Technologies's ADMA Position: Q2 2026 in Review

Entropy Technologies opened a new position in ADMA Biologics (ADMA) in Q2 2026: 22,602 shares worth $189K. The stake represents 0.01% of the portfolio and ranks #896 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in ADMA as recently as Q4 2025.

Entropy Technologies first reported a position in ADMA in Q3 2024 and has held it in 4 quarters since. The position peaked at $757K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Entropy Technologies held 22,602 shares of ADMA Biologics worth $189K as of Q2 2026.
  • ADMA Biologics was a new Entropy Technologies position in Q2 2026.
  • ADMA Biologics made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #896 holding.
  • Entropy Technologies first reported a position in ADMA Biologics in Q3 2024 and has held it in 4 quarters since.
  • Entropy Technologies's ADMA Biologics position peaked at $757K in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.